PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.15%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$843M
AUM Growth
+$843M
(+12%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
33.86%
Holding
109
New
20
Increased
44
Reduced
26
Closed
18
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$22.7M |
| 2 |
CVS Health
CVS
|
$21.5M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$19.6M |
| 4 |
UnitedHealth
UNH
|
$15.8M |
| 5 |
Revvity
RVTY
|
$14.8M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$29.2M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$20.3M |
| 3 |
Abbott
ABT
|
$20M |
| 4 |
Gilead Sciences
GILD
|
$17.5M |
| 5 |
Boston Scientific
BSX
|
$11.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Precigen
PGEN
$1.42B
| $4.76M | 0.56% |
+3,191,343
| New | +$4.76M |
|
52
Mineralys Therapeutics
MLYS
$1.94B
| $4.67M | 0.55% |
+293,928
| New | +$4.67M |
|
53
Amicus Therapeutics
FOLD
$2.42B
| $4.64M | 0.55% |
568,952
-215,424
| -27% | -$1.76M |
|
54
Alphatec Holdings
ATEC
$2.35B
| $4.52M | 0.54% |
446,106
+217,772
| +95% | +$2.21M |
|
55
Arcellx
ACLX
$3.95B
| $4.42M | 0.52% |
67,390
+22,898
| +51% | +$1.5M |
|
56
UroGen Pharma
URGN
$896M
| $4.35M | 0.52% |
393,153
+23,292
| +6% | +$258K |
|
57
Nurix Therapeutics
NRIX
$723M
| $4.16M | 0.49% |
350,420
-181,752
| -34% | -$2.16M |
|
58
Pulmonx
LUNG
$68M
| $4.12M | 0.49% |
611,875
+404,022
| +194% | +$2.72M |
|
59
OptimizeRx
OPRX
$326M
| $4.11M | 0.49% |
+475,000
| New | +$4.11M |
|
60
Guardant Health
GH
$8.11B
| $3.81M | 0.45% |
+89,329
| New | +$3.81M |
|
61
Vaxcyte
PCVX
$4.17B
| $3.53M | 0.42% |
93,431
-22,707
| -20% | -$857K |
|
62
SI-BONE Inc
SIBN
$700M
| $3.24M | 0.38% |
231,109
+14,509
| +7% | +$204K |
|
63
United Therapeutics
UTHR
$17.7B
| $3.15M | 0.37% |
10,232
-27,240
| -73% | -$8.4M |
|
64
InspireMD
NSPR
$101M
| $3.15M | 0.37% |
1,171,416
+316,700
| +37% | +$852K |
|
|
PHLT
65
Performant Healthcare, Inc. Common Stock
PHLT
$601M
| $3.14M | 0.37% |
1,060,601
-197,204
| -16% | -$584K |
|
66
Dynavax Technologies
DVAX
$1.19B
| $3.05M | 0.36% |
234,784
+13,804
| +6% | +$179K |
|
67
Insmed
INSM
$30.3B
| $2.89M | 0.34% |
37,901
+2,233
| +6% | +$170K |
|
68
Artivion
AORT
$2.04B
| $2.74M | 0.33% |
+111,652
| New | +$2.74M |
|
69
Terns Pharmaceuticals
TERN
$651M
| $2.65M | 0.31% |
959,703
+130,598
| +16% | +$360K |
|
70
Outset Medical
OM
$245M
| $2.56M | 0.3% |
+231,099
| New | +$2.56M |
|
|
MBX
71
MBX Biosciences, Inc. Common Stock
MBX
$484M
| $2.42M | 0.29% |
328,323
+158,323
| +93% | +$1.17M |
|
72
Keros Therapeutics
KROS
$640M
| $2.22M | 0.26% |
217,753
-96,788
| -31% | -$986K |
|
73
uniQure
QURE
$955M
| $2.16M | 0.26% |
203,833
-71,167
| -26% | -$754K |
|
74
Crinetics Pharmaceuticals
CRNX
$3.27B
| $2.14M | 0.25% |
63,940
+12,807
| +25% | +$430K |
|
75
NewAmsterdam Pharma
NAMS
$2.8B
| $2.07M | 0.25% |
100,955
+24,839
| +33% | +$508K |
|